Literature DB >> 24780048

Adipocyte size threshold matters: link with risk of type 2 diabetes and improved insulin resistance after gastric bypass.

Aurelie Cotillard1, Christine Poitou, Adriana Torcivia, Jean-Luc Bouillot, Arne Dietrich, Nora Klöting, Cécile Grégoire, Karine Lolmede, Matthias Blüher, Karine Clément.   

Abstract

CONTEXT: Adipocyte volume has been associated with insulin resistance and type 2 diabetes.
OBJECTIVE: Our purpose was to identify an adipocyte volume threshold linked with increased insulin resistance risk, and to examine its association with insulin resistance improvement after bariatric surgery. SETTING AND
DESIGN: We investigated two cohorts of Caucasian women, candidates for bariatric surgery, from two institutional centers in France (age 42.0 ± 11.5 years; body mass index, 47.6 ± 6.9 kg/m(2)) and Germany (age 41.3 ± 11.2 years; body mass index, 49.5 ± 8.1 kg/m(2)). 38% of the subjects had gastric bypass surgery and were followed for 6 months after the intervention. We defined a group of subjects with type 2 diabetes or at risk of type 2 diabetes (DRD) and investigated the relations between adipocyte volume and this status before and after surgery.
RESULTS: In both cohorts, subjects with DRD presented enlarged adipocytes (France, P = 3×10(-4); Germany, P =3×10(-10)) and we were able to determine thresholds in each cohort above which diabetes risk was potentially increased (France: 1003±42 pL, Germany: 798±32 pL). Subjects above those adipocyte thresholds were less prone to disappearance of the DRD status after bypass surgery (France, risk ratio = 2.1, P = .024; Germany, risk ratio = 1.3, P = .05).
CONCLUSIONS: We show in two cohorts of morbidly obese subjects that a specific adipocyte volume threshold may predict an increased risk for obesity-associated type 2 diabetes. However, this threshold might be established for each specific investigation site. Having a high adipocyte size is associated with a lower improvement of insulin resistance after bypass surgery in both cohorts.

Entities:  

Mesh:

Year:  2014        PMID: 24780048     DOI: 10.1210/jc.2014-1074

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  51 in total

1.  Adipose tissue morphology predicts improved insulin sensitivity following moderate or pronounced weight loss.

Authors:  D Eriksson-Hogling; D P Andersson; J Bäckdahl; J Hoffstedt; S Rössner; A Thorell; E Arner; P Arner; M Rydén
Journal:  Int J Obes (Lond)       Date:  2015-02-10       Impact factor: 5.095

2.  Adipose tissue fibrosis, hypertrophy, and hyperplasia: Correlations with diabetes in human obesity.

Authors:  Lindsey A Muir; Christopher K Neeley; Kevin A Meyer; Nicki A Baker; Alice M Brosius; Alexandra R Washabaugh; Oliver A Varban; Jonathan F Finks; Brian F Zamarron; Carmen G Flesher; Joshua S Chang; Jennifer B DelProposto; Lynn Geletka; Gabriel Martinez-Santibanez; Niko Kaciroti; Carey N Lumeng; Robert W O'Rourke
Journal:  Obesity (Silver Spring)       Date:  2016-03       Impact factor: 5.002

Review 3.  Does bariatric surgery improve adipose tissue function?

Authors:  H Frikke-Schmidt; R W O'Rourke; C N Lumeng; D A Sandoval; R J Seeley
Journal:  Obes Rev       Date:  2016-06-08       Impact factor: 9.213

Review 4.  Adipocyte dysfunction, inflammation and metabolic syndrome.

Authors:  Nora Klöting; Matthias Blüher
Journal:  Rev Endocr Metab Disord       Date:  2014-12       Impact factor: 6.514

Review 5.  Impact of bariatric surgery on type 2 diabetes: contribution of inflammation and gut microbiome?

Authors:  Jean Debédat; Chloé Amouyal; Judith Aron-Wisnewsky; Karine Clément
Journal:  Semin Immunopathol       Date:  2019-04-25       Impact factor: 9.623

Review 6.  Childhood obesity, bone development, and cardiometabolic risk factors.

Authors:  Norman K Pollock
Journal:  Mol Cell Endocrinol       Date:  2015-03-27       Impact factor: 4.102

7.  Adipocyte hypertrophy-hyperplasia balance contributes to weight loss after bariatric surgery.

Authors:  Lindsey A Muir; Nicki A Baker; Alexandra R Washabaugh; Christopher K Neeley; Carmen G Flesher; Jennifer B DelProposto; Lynn M Geletka; Amir A Ghaferi; Jonathan F Finks; Kanakadurga Singer; Oliver A Varban; Carey N Lumeng; Robert W O'Rourke
Journal:  Adipocyte       Date:  2017-01-27       Impact factor: 4.534

8.  Nck2, an unexpected regulator of adipogenesis.

Authors:  N Haider; J Dusseault; A Rudich; L Larose
Journal:  Adipocyte       Date:  2017-02-06       Impact factor: 4.534

Review 9.  Convertible visceral fat as a therapeutic target to curb obesity.

Authors:  Antonio Giordano; Andrea Frontini; Saverio Cinti
Journal:  Nat Rev Drug Discov       Date:  2016-03-11       Impact factor: 84.694

10.  Increased fat cell size: a major phenotype of subcutaneous white adipose tissue in non-obese individuals with type 2 diabetes.

Authors:  Juan R Acosta; Iyadh Douagi; Daniel P Andersson; Jesper Bäckdahl; Mikael Rydén; Peter Arner; Jurga Laurencikiene
Journal:  Diabetologia       Date:  2015-11-25       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.